FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger

The U.S. Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer advocates worried about youth use.

Nicotine pouches are placed in the mouth between the lip and gums. They are made of nicotine powder, flav...

Rehab Program Helps Lift Long COVID 'Brain Fog'

Many people with long COVID suffer from “brain fog,” finding it difficult to remember things, think on their feet or pay attention.

But this symptom can be addressed by rehab, according to a new study.

Ten weeks of cognitive rehabilitation helped long COVID patients lift much of their brain fog, allowing them to achieve g...

Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation

Why is your right hand so much better at everyday tasks like writing, throwing or using tools if you’re a righty, but your left hand if you’re a lefty?

A new study argues that your dominant hand is made, not born — in other words, practice determines whether you’re left- or right-handed.

There’s no hardw...

Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems

Here’s more pressure for harried mothers — a sluggish response to baby’s coos and babbles might increase their risk of childhood psychiatric problems.

Moms who respond within one second of their baby’s vocalizations appear to lower the child’s risk of mental health problems by age 7, researchers reported July ...

Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds

People living in rural America are more likely to view cancer as a death sentence, a new survey reports.

About 43% of people living in rural areas say a cancer diagnosis means inevitable death, compared to 35% of people in urban or suburban locales, according to the new poll from the Prevent Cancer Foundation.

This is likely driven b...

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel

Federal health scientists are urging caution about expanding access to controversial peptide drugs, even as the U.S. Food and Drug Administration (FDA) reshapes the advisory panel that will consider whether to loosen those restrictions.

FDA career scientists quietly posted recommendations online Monday in several briefing documents advisin...